Organisation paid for research Program year 2025 Source: CMS Open Payments

Valley Research

Neither a doctor nor a teaching hospital

Research payments

$2,625,470

3,018 payments

Through program year 2025, Valley Research is reported as receiving $2,625,470 in research payments, across 3,018 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$11,791	3
2024	Research	$76,516	30
2023	Research	$196,398	310
2022	Research	$354,553	358
2021	Research	$696,968	1,566
2020	Research	$276,631	426
2019	Research	$1,012,613	325

Breakdown

Who paid Research payments · program years 2019–2025

Novo Nordisk AS $2,279,912 2,935 payments
Pfizer Inc. $97,497 4 payments
Akcea Therapeutics, Inc. $81,316 5 payments
Medtronic, Inc. $70,948 16 payments
Abbott Laboratories $47,430 52 payments
AstraZeneca Pharmaceuticals LP $31,611 4 payments
Eli Lilly and Company $9,700 1 payment
Biogen, Inc. $7,056 1 payment

Studies the money was for Research payments · program years 2019–2025

Nn1436-4625 $319,672 452 payments
Nn1436-4478 $258,845 435 payments
Nn1250-4419 $250,655 112 payments
Nn9536-4375 $198,046 27 payments
Nn9535-4321 $168,760 429 payments
Nn1250-4252 $153,528 8 payments
Nn9536-4376 $137,504 32 payments
Nn9535-4801 $131,484 263 payments
Nn1436-4477 $119,881 361 payments
A Phase 3 Randomized Double Blind Placebo and Activecontrolled Multicenter Parallelgroup Study of the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects With Chronic Low Back Pain $97,497 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.